Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 1/2012

01.02.2012 | Original Paper

Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes

verfasst von: J. Angst, A. Gamma, C. L. Bowden, J. M. Azorin, G. Perugi, E. Vieta, A. H. Young

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 1/2012

Einloggen, um Zugang zu erhalten

Abstract

To assess the clinical validity of individual DSM-IV criteria for hypomania. In an international sample of 5,635 patients with major depressive episodes (Bridge Study), DSM-IV criteria for hypomania (stem questions, number and quality of symptoms, duration and exclusion criteria) were systematically assessed and their validity analysed on the basis of clinical data including family history, course, and other clinical characteristics. Three stem questions for hypomania, irritability, elevated mood and the added question of increased activity, showed comparable validity. The results support the current DSM-IV requirement for a higher symptom threshold (4 of 7 hypomanic symptoms) in cases of irritable mood. Longer durations of hypomanic episodes were associated with higher scores on all validators. The results did not support the DSM-IV durational requirements for hypomanic episodes (4 days) and manic episodes (7 days). Brief hypomanic episodes of 1, 2 or 3 days were valid and would meet validity criteria for inclusion. The three exclusion criteria in DSM-IV (hypomania due to the use of antidepressants or of other substances, or to other medical conditions) were found to exclude patients with bipolar depression and should therefore not be retained. These results support several revisions of the DSM-IV concept of hypomanic episodes: specifically, the inclusion of increased activity as a gate question, the inclusion of 1 or 2 to 3-day episodes and the elimination of all exclusion criteria.
Literatur
1.
Zurück zum Zitat Angst J (1992) Recurrent brief psychiatric syndromes of depression, hypomania, neurasthenia, and anxiety from an epidemiological point of view. Neurol Psychiatry Brain Res 1:5–12 Angst J (1992) Recurrent brief psychiatric syndromes of depression, hypomania, neurasthenia, and anxiety from an epidemiological point of view. Neurol Psychiatry Brain Res 1:5–12
2.
Zurück zum Zitat Angst J (1997) Recurrent brief psychiatric syndromes: hypomania, depression, anxiety and neurasthenia. In: Judd LL, Saletu B, Filip V (eds) Basic and clinical science of mental and addictive disorders. Karger, Basel Freiburg Paris, pp 33–38CrossRef Angst J (1997) Recurrent brief psychiatric syndromes: hypomania, depression, anxiety and neurasthenia. In: Judd LL, Saletu B, Filip V (eds) Basic and clinical science of mental and addictive disorders. Karger, Basel Freiburg Paris, pp 33–38CrossRef
3.
Zurück zum Zitat Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH, for the BRIDGE Study Group (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the Bridge Study. Arch Gen Psychiatry 68:791–799 Angst J, Azorin JM, Bowden CL, Perugi G, Vieta E, Young AH, for the BRIDGE Study Group (2011) Prevalence and characteristics of undiagnosed bipolar disorders in patients with a major depressive episode: the Bridge Study. Arch Gen Psychiatry 68:791–799
4.
Zurück zum Zitat Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler R, Merikangas K (2010) Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 167:1194–1201PubMedCrossRef Angst J, Cui L, Swendsen J, Rothen S, Cravchik A, Kessler R, Merikangas K (2010) Major depressive disorder with subthreshold bipolarity in the National Comorbidity Survey Replication. Am J Psychiatry 167:1194–1201PubMedCrossRef
5.
Zurück zum Zitat Bijl RV, Ravelli A, van Zerssen G (1998) Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33:587–595PubMedCrossRef Bijl RV, Ravelli A, van Zerssen G (1998) Prevalence of psychiatric disorder in the general population: results of the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Soc Psychiatry Psychiatr Epidemiol 33:587–595PubMedCrossRef
6.
Zurück zum Zitat Bowden CL, Angst J, Azorin JM, Perugi G, Vieta E, Young AH (in print) Significant bipolar risk factors in patients presenting a current major depressive episode (abstract). In: Proceedings of 163rd Annual Meeting. American Psychiatric Association, 22–26. May 2010, New Orleans Bowden CL, Angst J, Azorin JM, Perugi G, Vieta E, Young AH (in print) Significant bipolar risk factors in patients presenting a current major depressive episode (abstract). In: Proceedings of 163rd Annual Meeting. American Psychiatric Association, 22–26. May 2010, New Orleans
7.
Zurück zum Zitat De Graaf R, Bijl RV, Ten Have M, Beekman ATF, Vollebergh WAM (2004) Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 109:55–63PubMedCrossRef De Graaf R, Bijl RV, Ten Have M, Beekman ATF, Vollebergh WAM (2004) Rapid onset of comorbidity of common mental disorders: findings from the Netherlands Mental Health Survey and Incidence Study (NEMESIS). Acta Psychiatr Scand 109:55–63PubMedCrossRef
8.
Zurück zum Zitat Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM (2004) Antidepressants for bipolar depression: a systematic review of randomised controlled trials. Am J Psychiatry 161:1537–1547PubMedCrossRef Gijsman HJ, Geddes JR, Rendell JM, Nolen WA, Goodwin GM (2004) Antidepressants for bipolar depression: a systematic review of randomised controlled trials. Am J Psychiatry 161:1537–1547PubMedCrossRef
9.
Zurück zum Zitat Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S, Miklowitz DJ, Sachs GS, Thase ME (2007) Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 164:1348–1355PubMedCrossRef Goldberg JF, Perlis RH, Ghaemi SN, Calabrese JR, Bowden CL, Wisniewski S, Miklowitz DJ, Sachs GS, Thase ME (2007) Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD. Am J Psychiatry 164:1348–1355PubMedCrossRef
10.
Zurück zum Zitat Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen H-U (2008) ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 18:535–549PubMedCrossRef Goodwin GM, Anderson I, Arango C, Bowden CL, Henry C, Mitchell PB, Nolen WA, Vieta E, Wittchen H-U (2008) ECNP consensus meeting. Bipolar depression. Nice, March 2007. Eur Neuropsychopharmacol 18:535–549PubMedCrossRef
11.
Zurück zum Zitat Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, Pennell B-E, Walters EE, Zaslavsky A, Zheng H (2004) The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 13:69–92PubMedCrossRef Kessler RC, Berglund P, Chiu WT, Demler O, Heeringa S, Hiripi E, Pennell B-E, Walters EE, Zaslavsky A, Zheng H (2004) The US National Comorbidity Survey Replication (NCS-R): design and field procedures. Int J Methods Psychiatr Res 13:69–92PubMedCrossRef
12.
Zurück zum Zitat Lecrubier Y, Sheehan D et al (1998) The Mini International Neuropsychiatric Interview. Eur Psychiatry S4:198CrossRef Lecrubier Y, Sheehan D et al (1998) The Mini International Neuropsychiatric Interview. Eur Psychiatry S4:198CrossRef
13.
Zurück zum Zitat Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS (2003) Defining clinical phenotypes of juvenile mania. Am J Psychiatry 160:430–437PubMedCrossRef Leibenluft E, Charney DS, Towbin KE, Bhangoo RK, Pine DS (2003) Defining clinical phenotypes of juvenile mania. Am J Psychiatry 160:430–437PubMedCrossRef
14.
Zurück zum Zitat Licht R, Gijsman H, Nolen WA, Angst J (2008) Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce mania or cycle acceleration. Acta Psychiatr Scand 118:337–346PubMedCrossRef Licht R, Gijsman H, Nolen WA, Angst J (2008) Are antidepressants safe in the treatment of bipolar depression? A critical evaluation of their potential risk to induce mania or cycle acceleration. Acta Psychiatr Scand 118:337–346PubMedCrossRef
15.
Zurück zum Zitat Rich BA, Schmajuk M, Perez-Edgar KE, Fox NA, Pine DS, Leibenluft E (2007) Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation. Am J Psychiatry 164:309–317PubMedCrossRef Rich BA, Schmajuk M, Perez-Edgar KE, Fox NA, Pine DS, Leibenluft E (2007) Different psychophysiological and behavioral responses elicited by frustration in pediatric bipolar disorder and severe mood dysregulation. Am J Psychiatry 164:309–317PubMedCrossRef
16.
Zurück zum Zitat Smith DJ, Ghaemi SN, Craddock N (2008) The broad clinical spectrum of bipolar disorder: implications for research and practice. J Psychopharmacol 22:397–400PubMedCrossRef Smith DJ, Ghaemi SN, Craddock N (2008) The broad clinical spectrum of bipolar disorder: implications for research and practice. J Psychopharmacol 22:397–400PubMedCrossRef
17.
Zurück zum Zitat Truman CJ, Goldberg JF, Ghaemi SN, Baldassano CF, Wisniewki SR, Dennehy EB, Thase ME, Sachs GS (2007) Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 68:1472–1479PubMedCrossRef Truman CJ, Goldberg JF, Ghaemi SN, Baldassano CF, Wisniewki SR, Dennehy EB, Thase ME, Sachs GS (2007) Self-reported history of manic/hypomanic switch associated with antidepressant use: data from the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD). J Clin Psychiatry 68:1472–1479PubMedCrossRef
18.
Zurück zum Zitat Vieta E, Angst J, Azorin JM, Bowden CL, Perugi G, Young AH, BRIDGE Study Group (2010) Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire (poster PW01-39). 18th European Congress of Psychiatry, 27. February–2. March 2010, Munich. In: Eur Psychiatry Vieta E, Angst J, Azorin JM, Bowden CL, Perugi G, Young AH, BRIDGE Study Group (2010) Characteristics of patients with hypomanic symptoms presenting a current major depressive episode identified with the HCL-32 patient questionnaire (poster PW01-39). 18th European Congress of Psychiatry, 27. February–2. March 2010, Munich. In: Eur Psychiatry
19.
Zurück zum Zitat Vieta E, Phillips ML (2007) Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull 33:886–892PubMedCrossRef Vieta E, Phillips ML (2007) Deconstructing bipolar disorder: a critical review of its diagnostic validity and a proposal for DSM-V and ICD-11. Schizophr Bull 33:886–892PubMedCrossRef
20.
Zurück zum Zitat Vieta E, Suppes T (2008) Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord 10:163–178PubMedCrossRef Vieta E, Suppes T (2008) Bipolar II disorder: arguments for and against a distinct diagnostic entity. Bipolar Disord 10:163–178PubMedCrossRef
21.
Zurück zum Zitat Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, Holsboer F, Angst J (2009) Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 66:1341–1352PubMedCrossRef Zimmermann P, Brückl T, Nocon A, Pfister H, Lieb R, Wittchen H-U, Holsboer F, Angst J (2009) Heterogeneity of DSM-IV major depressive disorder as a consequence of subthreshold bipolarity. Arch Gen Psychiatry 66:1341–1352PubMedCrossRef
Metadaten
Titel
Diagnostic criteria for bipolarity based on an international sample of 5,635 patients with DSM-IV major depressive episodes
verfasst von
J. Angst
A. Gamma
C. L. Bowden
J. M. Azorin
G. Perugi
E. Vieta
A. H. Young
Publikationsdatum
01.02.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 1/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-011-0228-0

Weitere Artikel der Ausgabe 1/2012

European Archives of Psychiatry and Clinical Neuroscience 1/2012 Zur Ausgabe

ADHS-Medikation erhöht das kardiovaskuläre Risiko

16.05.2024 Herzinsuffizienz Nachrichten

Erwachsene, die Medikamente gegen das Aufmerksamkeitsdefizit-Hyperaktivitätssyndrom einnehmen, laufen offenbar erhöhte Gefahr, an Herzschwäche zu erkranken oder einen Schlaganfall zu erleiden. Es scheint eine Dosis-Wirkungs-Beziehung zu bestehen.

Typ-2-Diabetes und Depression folgen oft aufeinander

14.05.2024 Typ-2-Diabetes Nachrichten

Menschen mit Typ-2-Diabetes sind überdurchschnittlich gefährdet, in den nächsten Jahren auch noch eine Depression zu entwickeln – und umgekehrt. Besonders ausgeprägt ist die Wechselbeziehung laut GKV-Daten bei jüngeren Erwachsenen.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Spezielles Sportprogramm bei einer Reihe von psychischen Erkrankungen effektiv

08.05.2024 Psychotherapie Nachrichten

Sportliche Betätigung hilft nicht nur bei Depression, sondern auch in Gruppen von Patientinnen und Patienten mit unterschiedlichen psychischen Erkrankungen, wie Insomnie, Panikattacken, Agoraphobie und posttraumatischem Belastungssyndrom. Sie alle profitieren längerfristig.

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.